+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Culture Test Market - Global Forecast 2026-2032- Product Image
Blood Culture Test Market - Global Forecast 2026-2032- Product Image
Sale

Blood Culture Test Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4995116
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Blood Culture Test Market is projected to reach USD 6.03 Billion in 2026. It is expected to continue growing at a CAGR of 7.19%, reaching USD 9.23 Billion by 2032.

Blood culture testing remains the clinical reference standard for detecting bloodstream infection and confirming sepsis-causing bacteria and fungi. For hospitals, clinical laboratories, diagnostic manufacturers, and antimicrobial stewardship teams, the blood culture test is central to early pathogen identification, targeted antimicrobial therapy, infection control, and patient risk stratification.

The market is being shaped by the global burden of sepsis, which the World Health Organization links to approximately 49 million cases and 11 million deaths annually, and by rising antimicrobial resistance that increases the need for timely, organism-specific diagnosis. Automated blood culture systems, optimized sample collection, rapid organism identification, and susceptibility workflows are increasingly important as health systems seek to reduce time-to-result, avoid unnecessary broad-spectrum antibiotic exposure, and improve outcomes in emergency, intensive care, oncology, neonatal, and transplant settings.

Transformative Shifts in the Blood Culture Testing Landscape

The blood culture test landscape is shifting from conventional culture-only workflows toward integrated diagnostic pathways that combine automated incubation, continuous monitoring, molecular identification, antimicrobial susceptibility testing, and laboratory information system connectivity. This transformation is driven by pressure to shorten time to effective therapy while maintaining the specificity and clinical confidence associated with culture-based diagnosis.

Operationally, laboratories are prioritizing contamination reduction, standardized collection volumes, instrument uptime, and faster downstream identification once a bottle flags positive. Health systems are also aligning blood culture testing with sepsis bundles, antimicrobial stewardship programs, and infection prevention metrics, making diagnostic performance a strategic quality indicator rather than a standalone laboratory function.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating a cumulative impact across the blood culture workflow by improving prediction, prioritization, and interpretation. AI-enabled clinical decision support can help identify patients at elevated sepsis risk, prompt appropriate blood culture collection before antibiotics, and reduce delays in emergency and inpatient care pathways. In the laboratory, machine learning can support signal interpretation, workload forecasting, bottle positivity analytics, contamination monitoring, and quality management.

The greatest near-term value is expected from AI that is embedded into validated clinical workflows rather than used as a replacement for microbiology expertise. When paired with electronic health records, antimicrobial stewardship data, and instrument outputs, AI can help reduce avoidable repeat testing, flag possible contaminants, accelerate escalation for critical results, and support more consistent reporting across high-volume hospital networks.

Key Regional Insights

Asia-Pacific is one of the most dynamic regions for blood culture test adoption, supported by expanding hospital infrastructure, high infectious disease burden, and rising investment in automated microbiology in China, India, Japan, South Korea, and Australia. Demand is reinforced by antimicrobial resistance surveillance needs, the expansion of private laboratory networks in urban centers, and increased focus on sepsis care in tertiary hospitals.

North America is characterized by mature hospital diagnostics, strong sepsis quality initiatives, antimicrobial stewardship mandates, and broad use of automated blood culture platforms. Latin America is advancing through public health modernization and private hospital growth, although access, reimbursement variability, and laboratory infrastructure gaps remain important constraints. Europe benefits from established antimicrobial stewardship frameworks, regional regulatory harmonization for in vitro diagnostics, and strong clinical microbiology standards. The Middle East, particularly high-income Gulf markets, is investing in advanced hospital laboratories and infection control capacity, while Africa continues to face access gaps but represents a critical region for bloodstream infection diagnosis due to infectious disease burden, neonatal sepsis risk, and the need for scalable diagnostic capacity.

Key Group Insights

ASEAN markets are expanding blood culture testing capacity as governments strengthen hospital networks, infectious disease surveillance, and laboratory accreditation, with demand supported by urban tertiary care growth and rising antimicrobial resistance awareness. The GCC is investing in high-throughput automated microbiology systems as part of broader healthcare modernization programs, medical city development, and tertiary care expansion. The European Union continues to influence global standards through in vitro diagnostic regulation, antimicrobial resistance action plans, and coordinated public health surveillance.

BRICS economies represent a major growth base because of large patient populations, rising healthcare expenditure, and urgent antimicrobial resistance priorities across Brazil, Russia, India, China, and South Africa. G7 countries lead in installed diagnostic infrastructure, stewardship integration, laboratory quality systems, and adoption of rapid adjunct technologies. NATO countries show strong demand resilience due to healthcare security priorities, military medicine requirements, and the need for dependable diagnostics during outbreaks, conflict-related care, and cross-border health emergencies.

Key Country Insights

The United States leads through advanced sepsis protocols, large hospital networks, and CDC-driven attention to antimicrobial resistance and healthcare-associated infections. Canada emphasizes standardized laboratory quality and stewardship, while Mexico and Brazil are expanding diagnostic access through mixed public-private healthcare systems. The United Kingdom, Germany, France, Italy, and Spain maintain strong clinical microbiology capabilities, with Germany and France showing notable strength in laboratory automation, antimicrobial stewardship, and hospital-based infectious disease management.

Russia continues to require robust bloodstream infection testing across large regional healthcare systems. China is scaling automated diagnostics rapidly as hospital volumes increase and antimicrobial resistance surveillance becomes more important. India has strong long-term demand driven by sepsis burden, private hospital investment, neonatal and intensive care needs, and the requirement for broader diagnostic access. Japan, Australia, and South Korea are advanced markets with high expectations for quality, automation, and rapid results, supported by mature hospital systems, infection control programs, and strong laboratory governance.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize workflow-integrated innovation that reduces time to organism identification without compromising culture reliability. This includes improving pre-analytical collection quality, optimizing blood volume compliance, integrating rapid identification from positive bottles, strengthening antimicrobial susceptibility workflows, and enabling seamless connectivity with laboratory information systems and antimicrobial stewardship platforms.

Commercial strategy should align with regional readiness. Mature markets need automation, analytics, interoperability, and evidence of clinical utility, while emerging markets need scalable instruments, training, service reliability, and cost-efficient consumables. Vendors and laboratories should also invest in contamination prevention, local validation studies, regulatory readiness, resilient supply chains, and partnerships with hospitals, public health agencies, and stewardship teams.

Research Methodology

This executive summary is based on secondary research from authoritative healthcare, public health, regulatory, and clinical microbiology sources, including global sepsis and antimicrobial resistance evidence from the World Health Organization, national public health agencies, peer-reviewed clinical guidance, and recognized laboratory practice standards. The analysis focuses on verified adoption drivers, workflow trends, regional healthcare dynamics, and technology developments relevant to blood culture testing.

Insights were synthesized through a structured review of disease burden, hospital laboratory modernization, antimicrobial stewardship priorities, diagnostic workflow evolution, regulatory direction, and regional health system capacity. The methodology avoids unverified market sizing claims and emphasizes data-backed directional intelligence suitable for decision-making, and strategic planning.

Conclusion

Blood culture testing remains indispensable in the diagnosis and management of bloodstream infections, particularly as sepsis mortality, antimicrobial resistance, and hospital quality requirements intensify the need for reliable microbiology. The landscape is moving toward faster, more connected, and more automated workflows that preserve the diagnostic authority of culture while accelerating clinical action.

Organizations that combine validated technology, strong laboratory practices, antimicrobial stewardship integration, and regionally tailored execution will be best positioned to support clinical value. The next phase of the blood culture test landscape will be defined by speed, accuracy, workflow intelligence, and equitable access to high-quality bloodstream infection diagnostics.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Blood Culture Test Market, by Product
7.1. Introduction
7.2. Consumables
7.2.1. Bottles
7.2.2. Culture Media
7.2.3. Reagent Kits
7.3. Instruments
7.3.1. Analyzers
7.3.2. Automation Systems
8. Blood Culture Test Market, by Technology
8.1. Introduction
8.2. Conventional
8.3. Molecular
8.3.1. Next Generation Sequencing
8.3.2. Polymerase Chain Reaction
9. Blood Culture Test Market, by Test Type
9.1. Introduction
9.2. Automated
9.3. Manual
10. Blood Culture Test Market, by Sample Type
10.1. Introduction
10.2. Plasma
10.3. Whole Blood
11. Blood Culture Test Market, by Mode
11.1. Introduction
11.2. Central Lab
11.3. Point Of Care
11.3.1. Bedside
11.3.2. Portable
12. Blood Culture Test Market, by End User
12.1. Introduction
12.2. Ambulatory Care Centers
12.2.1. Independent Clinics
12.2.2. Physician Offices
12.3. Blood Banks
12.4. Diagnostic Laboratories
12.4.1. Hospital Based Labs
12.4.2. Independent Labs
12.5. Hospitals & Clinics
12.5.1. Secondary Hospitals
12.5.2. Tertiary Hospitals
13. Blood Culture Test Market, by Application
13.1. Introduction
13.2. Bacterial
13.2.1. Gram Negative
13.2.2. Gram Positive
13.3. Fungal
13.3.1. Filamentous Fungi
13.3.2. Yeast
13.4. Mycobacterial
14. Blood Culture Test Market, by Region
14.1. Asia-Pacific
14.2. North America
14.3. Latin America
14.4. Europe
14.5. Middle East
14.6. Africa
15. Blood Culture Test Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Blood Culture Test Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. FPNV Positioning Matrix, 2025
17.3. Market Concentration Analysis, 2025
17.3.1. Concentration Ratio (CR)
17.3.2. Herfindahl Hirschman Index (HHI)
17.4. Recent Developments & Impact Analysis, 2025
17.5. Product Portfolio Analysis, 2025
17.6. Benchmarking Analysis, 2025
18. Company Profiles
18.1. Abbott Laboratories
18.2. Anaerobe Systems, Inc.
18.3. Autobio Diagnostics Co., Ltd.
18.4. Becton, Dickinson and Company
18.5. BINDER GmbH
18.6. Biobase Biodusty(Shandong), Co., Ltd.
18.7. Biomérieux SA
18.8. Bruker Corporation
18.9. Danaher Corporation
18.10. Devyser AB
18.11. Eli Lilly and Company
18.12. F. Hoffmann-La Roche Ltd.
18.13. HiMedia Laboratories Pvt. Ltd.
18.14. Juno Diagnostics, Inc.
18.15. Neogen Corporation
18.16. Novartis AG
18.17. OpGen, Inc.
18.18. Scenker Biological Technology Co., Ltd.
18.19. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
18.20. Siemens Healthineers AG
18.21. T2 Biosystems, Inc.
18.22. Terumo Corporation
18.23. Thermo Fisher Scientific, Inc.
18.24. ZeptoMetrix Corporation
List of Figures
FIGURE 1. GLOBAL BLOOD CULTURE TEST MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL BLOOD CULTURE TEST MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL BLOOD CULTURE TEST MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL BLOOD CULTURE TEST MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL BLOOD CULTURE TEST MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 7. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 23. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 25. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL BLOOD CULTURE TEST MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 27. GLOBAL BLOOD CULTURE TEST MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL BLOOD CULTURE TEST MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL BLOOD CULTURE TEST MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CONSUMABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CONSUMABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CONSUMABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL BOTTLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL BOTTLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL BOTTLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL CULTURE MEDIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL CULTURE MEDIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL REAGENT KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL REAGENT KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL REAGENT KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL ANALYZERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL ANALYZERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL ANALYZERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL AUTOMATION SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL AUTOMATION SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL AUTOMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL CONVENTIONAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL CONVENTIONAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CONVENTIONAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL MOLECULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL MOLECULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL MOLECULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL AUTOMATED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL AUTOMATED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL AUTOMATED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL MANUAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL MANUAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL MANUAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL PLASMA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL PLASMA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL PLASMA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL WHOLE BLOOD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL WHOLE BLOOD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL WHOLE BLOOD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL CENTRAL LAB MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL CENTRAL LAB MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL CENTRAL LAB MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL POINT OF CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL POINT OF CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL POINT OF CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL BEDSIDE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL BEDSIDE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL BEDSIDE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL PORTABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL PORTABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL PORTABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL INDEPENDENT CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL INDEPENDENT CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL INDEPENDENT CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL PHYSICIAN OFFICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL PHYSICIAN OFFICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL PHYSICIAN OFFICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL BLOOD BANKS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL BLOOD BANKS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL BLOOD BANKS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL HOSPITAL BASED LABS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL HOSPITAL BASED LABS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL HOSPITAL BASED LABS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL INDEPENDENT LABS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL INDEPENDENT LABS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL INDEPENDENT LABS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL SECONDARY HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL SECONDARY HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL SECONDARY HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL TERTIARY HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL TERTIARY HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL TERTIARY HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL BACTERIAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL BACTERIAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL BACTERIAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL GRAM NEGATIVE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL GRAM NEGATIVE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL GRAM NEGATIVE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL GRAM POSITIVE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL GRAM POSITIVE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL GRAM POSITIVE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL FUNGAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL FUNGAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL FUNGAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL FILAMENTOUS FUNGI MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL FILAMENTOUS FUNGI MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL FILAMENTOUS FUNGI MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL YEAST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL YEAST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL YEAST MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL MYCOBACTERIAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL MYCOBACTERIAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL MYCOBACTERIAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2017-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2017-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2017-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2017-2032 (USD MILLION)
TABLE 136. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 137. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 138. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 139. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 140. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 141. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2017-2032 (USD MILLION)
TABLE 142. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 143. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 144. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2017-2032 (USD MILLION)
TABLE 145. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 146. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 147. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 148. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 149. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 150. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 151. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2017-2032 (USD MILLION)
TABLE 152. NORTH AMERICA BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2017-2032 (USD MILLION)
TABLE 153. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 154. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 155. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 156. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 157. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 158. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2017-2032 (USD MILLION)
TABLE 159. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 160. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 161. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2017-2032 (USD MILLION)
TABLE 162. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 163. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 164. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 165. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 166. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 167. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 168. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2017-2032 (USD MILLION)
TABLE 169. LATIN AMERICA BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2017-2032 (USD MILLION)
TABLE 170. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 171. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 172. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 173. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 174. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 175. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2017-2032 (USD MILLION)
TABLE 176. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 177. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 178. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2017-2032 (USD MILLION)
TABLE 179. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 180. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 181. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 182. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 183. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 184. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 185. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2017-2032 (USD MILLION)
TABLE 186. EUROPE BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2017-2032 (USD MILLION)
TABLE 187. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 188. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 189. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 190. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 191. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 192. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2017-2032 (USD MILLION)
TABLE 193. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 194. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 195. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2017-2032 (USD MILLION)
TABLE 196. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 197. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 198. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 199. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 200. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 201. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 202. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2017-2032 (USD MILLION)
TABLE 203. MIDDLE EAST BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2017-2032 (USD MILLION)
TABLE 204. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 205. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 206. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 207. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 208. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 209. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2017-2032 (USD MILLION)
TABLE 210. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 211. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 212. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2017-2032 (USD MILLION)
TABLE 213. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 214. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 215. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 216. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 217. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 218. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 219. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2017-2032 (USD MILLION)
TABLE 220. AFRICA BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2017-2032 (USD MILLION)
TABLE 221. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 222. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 223. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 224. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 225. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 226. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 227. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2017-2032 (USD MILLION)
TABLE 228. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 229. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 230. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2017-2032 (USD MILLION)
TABLE 231. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 232. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 233. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 234. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 235. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 236. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 237. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2017-2032 (USD MILLION)
TABLE 238. ASEAN BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2017-2032 (USD MILLION)
TABLE 239. GCC BLOOD CULTURE TEST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 240. GCC BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 241. GCC BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 242. GCC BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 243. GCC BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 244. GCC BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2017-2032 (USD MILLION)
TABLE 245. GCC BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 246. GCC BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 247. GCC BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2017-2032 (USD MILLION)
TABLE 248. GCC BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 249. GCC BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 250. GCC BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 251. GCC BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 252. GCC BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 253. GCC BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 254. GCC BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2017-2032 (USD MILLION)
TABLE 255. GCC BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2017-2032 (USD MILLION)
TABLE 256. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 258. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 259. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 261. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2017-2032 (USD MILLION)
TABLE 262. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 263. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 264. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2017-2032 (USD MILLION)
TABLE 265. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 267. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2017-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2017-2032 (USD MILLION)
TABLE 273. BRICS BLOOD CULTURE TEST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 274. BRICS BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 275. BRICS BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 276. BRICS BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 277. BRICS BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 278. BRICS BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2017-2032 (USD MILLION)
TABLE 279. BRICS BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 280. BRICS BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 281. BRICS BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2017-2032 (USD MILLION)
TABLE 282. BRICS BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 283. BRICS BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 284. BRICS BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 285. BRICS BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 286. BRICS BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 287. BRICS BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 288. BRICS BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2017-2032 (USD MILLION)
TABLE 289. BRICS BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2017-2032 (USD MILLION)
TABLE 290. G7 BLOOD CULTURE TEST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 291. G7 BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 292. G7 BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 293. G7 BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 294. G7 BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 295. G7 BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2017-2032 (USD MILLION)
TABLE 296. G7 BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 297. G7 BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 298. G7 BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2017-2032 (USD MILLION)
TABLE 299. G7 BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 300. G7 BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 301. G7 BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 302. G7 BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 303. G7 BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 304. G7 BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 305. G7 BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2017-2032 (USD MILLION)
TABLE 306. G7 BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2017-2032 (USD MILLION)
TABLE 307. NATO BLOOD CULTURE TEST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 308. NATO BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 309. NATO BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 310. NATO BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 311. NATO BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 312. NATO BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2017-2032 (USD MILLION)
TABLE 313. NATO BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 314. NATO BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 315. NATO BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2017-2032 (USD MILLION)
TABLE 316. NATO BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 317. NATO BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 318. NATO BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 319. NATO BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 320. NATO BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 321. NATO BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 322. NATO BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2017-2032 (USD MILLION)
TABLE 323. NATO BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2017-2032 (USD MILLION)
TABLE 324. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 325. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 326. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 327. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 328. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 329. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 330. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2017-2032 (USD MILLION)
TABLE 331. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 332. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 333. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2017-2032 (USD MILLION)
TABLE 334. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 335. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 336. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 337. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 338. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 339. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 340. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2017-2032 (USD MILLION)
TABLE 341. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2017-2032 (USD MILLION)
TABLE 342. CANADA BLOOD CULTURE TEST MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 343. CANADA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 344. CANADA BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 345. CANADA BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 346. CANADA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 347. CANADA BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2017-2032 (USD MILLION)
TABLE 348. CANADA BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 349. CANADA BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 350. CANADA BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2017-2032 (USD MILLION)
TABLE 351. CANADA BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 352. CANADA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 353. CANADA BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 354. CANADA BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 355. CANADA BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 356. CANADA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 357. CANADA BLOOD CULTURE TEST MARKET SIZE, BY BACTERIAL, 2017-2032 (USD MILLION)
TABLE 358. CANADA BLOOD CULTURE TEST MARKET SIZE, BY FUNGAL, 2017-2032 (USD MILLION)
TABLE 359. MEXICO BLOOD CULTURE TEST MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 360. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 361. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 362. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 363. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 364. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR, 2017-2032 (USD MILLION)
TABLE 365. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 366. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 367. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY MODE, 2017-2032 (USD MILLION)
TABLE 368. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 369. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 370. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 371. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 372. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (US

Companies Mentioned

  • Abbott Laboratories
  • Anaerobe Systems, Inc.
  • Autobio Diagnostics Co., Ltd.
  • Becton, Dickinson and Company
  • BINDER GmbH
  • Biobase Biodusty(Shandong), Co., Ltd.
  • Biomérieux SA
  • Bruker Corporation
  • Danaher Corporation
  • Devyser AB
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • HiMedia Laboratories Pvt. Ltd.
  • Juno Diagnostics, Inc.
  • Neogen Corporation
  • Novartis AG
  • OpGen, Inc.
  • Scenker Biological Technology Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • T2 Biosystems, Inc.
  • Terumo Corporation
  • Thermo Fisher Scientific, Inc.
  • ZeptoMetrix Corporation

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 6.03 Billion
Forecasted Market Value ( USD ) by 2032 $ 9.23 Billion
Compound Annual Growth Rate7.1%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Blood Culture Tests - Global Strategic Business Report - Product Image

Blood Culture Tests - Global Strategic Business Report

  • Report
  • 471 Pages
  • Global
From
Blood Culture Test - A Global Market Overview - Product Image

Blood Culture Test - A Global Market Overview

  • Report
  • 405 Pages
  • Global
From
Blood Culture Test Market Size, Share, Trends and Forecast by Testing Method, Product, Technology, Application, End User, and Region, 2026-2034 - Product Image

Blood Culture Test Market Size, Share, Trends and Forecast by Testing Method, Product, Technology, Application, End User, and Region, 2026-2034

  • Report
  • 150 Pages
  • Global
From
Blood Culture Tests Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030 - Product Image

Blood Culture Tests Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

  • Report
  • 180 Pages
  • Global
From
Blood Culture Tests Market Report 2026 - Product Image

Blood Culture Tests Market Report 2026

  • Report
  • 250 Pages
  • Global
From

About the Blood Culture Test Market

The Blood Culture Test is a type of infectious disease testing used to detect the presence of bacteria, fungi, or other microorganisms in the blood. It is used to diagnose and monitor the treatment of a variety of infections, including sepsis, endocarditis, and meningitis. The test involves collecting a sample of blood and culturing it in a laboratory to identify any microorganisms present. Results are typically available within 24 to 48 hours. The Blood Culture Test market is a growing segment of the infectious disease testing industry. It is used in both clinical and research settings, and is increasingly being used to diagnose and monitor infections in the community. The market is driven by the increasing prevalence of infectious diseases, the need for rapid diagnosis, and the development of new technologies. Companies in the Blood Culture Test market include Becton Dickinson, bioMérieux, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.